LyGenesis has embarked on a groundbreaking phase II trial focusing on the growth of liver organoids in patient lymph nodes. This innovative approach aims to address the critical shortage of donor livers available for transplantation, offering hope to thousands of individuals suffering from liver disease. By injecting donor cells into lymph nodes near the liver, LyGenesis is paving the way for the creation of miniature livers that can effectively replace damaged tissue and restore vital functions. This trial holds promise for revolutionizing organ transplantation and potentially expanding to other organs in the future.
LyGenesis Commences Phase II Trial for Growth of Liver Organoids in Patient Lymph Nodes – Fight Aging!
Leave a comment
